Press Releases

Drug and Gene Delivery Systems Market Size, Share, Growrh Rates, Trends and Forecast to 2022-2030

Share This Article

Drug and Gene Delivery Systems Market: Outlook

The segments in the global drug and gene delivery systems market based on the system of delivery consist of drug delivery systems (such as prodrug implants, targeted drug delivery, intrauterine implants, and polymeric drug delivery) and gene delivery systems (such as non-viral gene delivery as well as viral gene delivery systems). The viral gene delivery systems segment can be further classified into sub-sections such as lentivirus vector, adeno-associated virus vector, herpes simplex virus vector, adenovirus vector, retrovirus vector, and Sendai virus vector, among others. Moreover, the non-viral gene delivery system segment is further divided into physical methods, natural organic compounds, and chemical methods.

Get the sample copy of report@ https://qyresearchmedical.com/sample/112017

The increasing prevalence of chronic diseases including diabetes and cancer is influencing the demand within the global drug and gene delivery systems market in coming years. Furthermore, the rising prevalence of cardiovascular diseases around the world is also supplementing the development trajectory of the global drug and gene delivery systems market. The segments in the global drug and gene delivery systems market based on the route of administration are injectable, transdermal, nasal, oral, inhalation, ocular, and topical. Some of the leading application segments for the products and solutions within the global drug and gene delivery systems market include oncology, urology, CNS, infectious diseases, ophthalmology, and diabetes, among others.

North America Holds the Largest Share in Drug and Gene Delivery Systems Market

Major geographical regions and leading nations functional within the global drug and gene delivery systems market include Europe (including the United Kingdom, France, Germany, Italy, Spain, and rest of the Europe), North America (including Canada and the United States), Asia Pacific (including China, Australia, India, Japan, New Zealand, and rest of the Asia Pacific), Middle East and Africa (including South Africa, the Gulf Cooperation Council countries, Israel, and rest of the Middle East and Africa), and Latin America (including Mexico, Brazil, and rest of the Latin America).

Regionally, North America accounted for the largest share in the global drug and gene delivery systems market in recent past, owing to rising prevalence of various chronic diseases in the United States. Furthermore, another region expected to perform admirably within the global drug and gene delivery systems market in the next few years is Asia Pacific. The development of the global drug and gene delivery systems market in Asia Pacific can be attributed to rising prevalence of HIV and cancer in the regional economies. Furthermore, high prevalence of HIV in Saudi Arabia and South Africa is expected to lead the global drug and gene delivery systems market in Middle East and Africa in near future.

View full report@ https://qyresearchmedical.com/report/drug-and-gene-delivery-systems-market-delivery-system-drug-delivery-systems-gene-delivery-systems-route-of-administration-oral-injectable-inhalation-transdermal-ocular-nasal-topical-application-infec-2017-2030/112017

Players in Drug and Gene Delivery Systems Market Engaged in Portfolio Diversification

Few of the leading incumbent players and manufacturers operational within the global drug and gene delivery systems market include Pfizer, Inc., AstraZeneca PLC, SiBiono GeneTech Co., Human Stem Cells Institute, Johnson & Johnson, Becton, Dickinson and Company, Oxford BioMedica, Amgen Inc., Bayer AG, Shanghai Sunway Biotech Co., Ltd., F. Hoffmann La Roche Ltd., and Novartis AG, among others. Players in the global drug and gene delivery systems market are focused on adopting new and advanced drug development and gene delivery systems in order to diversify their product portfolios.

For example, Becton, Dickinson, and Company launched a new circulating cell free DNA collection tube called PAXgene, intended for prenatal cancer testing in February of 2018. Similarly, Novartis Access was launched by the Novartis AG in Kenya in October of 2015 with an aim to provide the countrymen with their portfolio of 15 affordable drugs, aimed at treating diabetes, breast cancer, respiratory disorders, and cardiovascular disorders.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/112017/2900

The drug and gene delivery systems market has been segmented as follows:

Delivery System

  • Drug Delivery Systems
  • Intrauterine Implants
  • Prodrug Implants
  • Polymeric Drug Delivery
  • Targeted Drug Delivery
  • Gene Delivery Systems
  • Viral Gene Delivery
  • Adenovirus Vector
  • Lentivirus Vector
  • Retrovirus Vector
  • Adeno-associated Virus Vector
  • Sendai Virus Vector
  • Herpes Simplex Virus Vector
  • Others
  • Non-viral Gene Delivery
  • Natural Organic Compounds
  • Physical Methods
  • Chemical Methods
  • Combined Hybrid System

Route of Administration

  • Oral
  • Injectable
  • Inhalation
  • Transdermal
  • Ocular
  • Nasal
  • Topical

Application

  • Infectious Diseases
  • Oncology
  • Ophthalmology
  • Urology
  • Diabetes
  • CNS
  • Others

Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of LATAM
  • Middle East & Africa
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

TABLE OF CONTENT

Section 1 Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Section 2 Assumptions and Research Methodology

Section 3 Executive Summary

Section 4 Market Overview
4.1. Product Definitions
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3 Opportunities
4.4. Global Drug and Gene Delivery System Market Forecast
4.5. Porter’s Five Forces Analysis
4.6. Global Drug and Gene Delivery System Market Outlook
4.7. Technological Advancements in Drug and Gene Delivery Products
4.8. Regulatory Scenario
4.9. Key Mergers & Acquisitions
4.10. Drug and Gene Therapy Pipeline

Section 5 Global Drug and Gene Delivery Systems Market Analysis, by Delivery System
5.1. Key Findings / Developments
5.2. Introduction: Drug Delivery Systems
5.3. Introduction: Gene Delivery Systems
5.4. Introduction & Definitions
5.5. Global Drug and Gene Delivery Systems Market Value Share Analysis, by Drug Delivery System
5.6. Global Drug and Gene Delivery Systems Market Value Share Analysis, by Gene Delivery System
5.7. Global Drug and Gene Delivery Systems Market Forecast, by Drug Delivery System
5.7.1.      Intrauterine Implants
5.7.2. Prodrug Implants
5.7.3. Polymeric Drug Delivery
5.7.4. Targeted Drug Delivery
5.8. Global Drug and Gene Delivery Systems Market Forecast, by Gene Delivery System
5.8.1. Viral Gene Delivery
5.8.2. Non-viral Gene Delivery
5.8.3. Combined Hybrid Systems
5.9. Global Drug and Gene Delivery Systems Market Forecast, by Gene Delivery System: Viral Gene Delivery
5.9.1. Adenovirus Vector
5.9.2. Lentivirus Vector
5.9.3. Retrovirus Vector
5.9.4. Adeno-associated Virus Vector
5.9.5. Sendai Virus Vector
5.9.6. Herpes Simplex Virus Vector
5.9.7. Others
5.10. Global Drug and Gene Delivery Systems Market Forecast, by Gene Delivery System: Non-viral Gene Delivery
5.10.1. Natural Organic Compounds
5.10.2. Physical Methods
5.10.3. Chemical Methods
5.11. Global Drug and Gene Delivery Systems Market Analysis, by Drug Delivery System
5.12. Global Drug and Gene Delivery Systems Market Analysis, by Gene Delivery System
5.13. Global Drug and Gene Delivery Systems Market Analysis, by Gene Delivery System: Viral Gene Delivery
5.14. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Drug Delivery System
5.15. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Gene Delivery System

Section 06 Global Drug and Gene Delivery System Market Analysis, by Application
6.1. Key Findings / Developments
6.2. Introduction & Definitions
6.3. Introduction: Drug Delivery Systems
6.4. Introduction: Gene Delivery Systems
6.5. Global Drug Delivery System Market Value Share Analysis, by Application
6.6. Global Gene Delivery System Market Value Share Analysis, by Application
6.7. Global Drug Delivery System Market Forecast, by Application
6.8.1. Infectious Diseases
6.8.2. Oncology
6.8.3. Ophthalmology
6.8.4. Urology
6.8.5. Diabetes
6.8.6. CNS
6.8.7. Others
6.9. Global Gene Delivery System Market Forecast, by Application
6.9.1. Infectious Diseases
6.9.2. Oncology
6.9.3. Ophthalmology
6.9.4. Urology
6.9.5. Diabetes
6.9.6. CNS
6.9.7. Others
6.10. Global Drug Delivery System Market Attractiveness, by Application
6.11. Global Gene Delivery System Market Attractiveness, by Application

Section 07 Global Drug and Gene Delivery Systems Market Analysis, by Route of Administration
7.1. Key Findings
7.2. Introduction & Definitions
7.3. Introduction: Drug Delivery Systems
7.4. Introduction: Gene Delivery Systems
7.5. Global Drug Delivery Systems Market, by Route of Administration
7.6. Global Gene Delivery Systems Market Value Share Analysis, by Route of Administration
7.7. Global Drug Delivery Systems Market Forecast, by Route of Administration
7.7.1. Oral
7.7.2. Injectable
7.7.3. Inhalation
7.7.4. Transdermal
7.7.5. Ocular
7.7.6. Nasal
7.7.7. Topical
7.8. Global Gene Delivery Systems Market Forecast, by Route of Administration
7.8.1. Oral
7.8.2. Injectable
7.8.3. Inhalation
7.8.4. Transdermal
7.8.5. Ocular
7.8.6. Nasal
7.8.7. Topical
7.9. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Drug Delivery: Route of Administration
7.10. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Gene Delivery: Route of Administration

Section 08 Global Drug and Gene Delivery Systems Market Analysis, by Region
8.1. Global Drug and Gene Delivery System Market Overview
8.2. Introduction
8.3. Global Drug and Gene Delivery System Market Value Share Analysis, by Region
8.4. Global Drug and Gene Delivery System Market Forecast, by Region
8.4.1. North America
8.4.2. Europe
8.4.3. Asia Pacific
8.4.4. Middle East & Africa
8.4.5. Latin America
8.5. Global Drug and Gene Delivery System Market Attractiveness Analysis, by Region

Section 09 North America Drug and Gene Delivery System Market Analysis
9.1. Key Findings
9.2. North America Drug and Gene Delivery System Market Overview
9.3. North America Drug and Gene Delivery System Market Overview, by Country
9.4. North America Drug and Gene Delivery System Market Value Share Analysis, by Country
9.5. North America Drug Delivery System Market Forecast, by Country
9.5.1. U.S.
9.5.2. Canada
9.6. North America Gene Delivery System Market Forecast, by Country
9.6.1. U.S.
9.6.2. Canada
9.7. North America Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
9.8. North America Drug and Gene Delivery System Market Forecast, by Drug Delivery System
9.8.1. Intrauterine Implants
9.8.2. Prodrug Implants
9.8.3. Polymeric Drug Delivery
9.8.4. Targeted Drug Delivery
9.9. North America Drug and Gene Delivery System Market Forecast, by Gene Delivery System
9.9.1. Viral Gene Delivery
9.9.2. Non-viral Gene Delivery
9.9.3. Combined Hybrid System
9.10. North America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
9.11. North America Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
9.12. North America Gene Delivery System Market Forecast, by Viral Gene Delivery
9.12.1. Adenovirus Vector
9.12.2. Lentivirus Vector
9.12.3. Retrovirus Vector
9.12.4. Adeno-associated Virus Vector
9.12.5. Sendai Virus Vector
9.12.6. Herpes Simplex Virus Vector
9.12.7. Others
9.13. North America Gene Delivery System Market Forecast, by Non-viral Gene Delivery
9.13.1. Natural Organic Compounds
9.13.2. Physical Methods
9.13.3. Chemical Methods
9.14. North America Drug and Gene Delivery System Market Value Share Analysis, by Application
9.15. North America Drug Delivery System Market Forecast, by Application
9.15.1. Infectious Diseases
9.15.2. Oncology
9.15.3. Ophthalmology
9.15.4. Urology
9.15.5. Diabetes
9.15.6. CNS
9.15.7. Others
9.16. North America Gene Delivery System Market Forecast, by Application
9.16.1. Infectious Diseases
9.16.2. Oncology
9.16.3. Ophthalmology
9.16.4. Urology
9.16.5. Diabetes
9.16.6. CNS
9.16.7. Others
9.17. North America Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
9.18. North America Drug Delivery System Market Forecast, by Route of Administration
9.18.1. Oral
9.18.2. Injectable
9.18.3. Inhalation
9.18.4. Transdermal
9.18.5. Ocular
9.18.6. Nasal
9.18.7. Topical
9.19. North America Gene Delivery System Market Forecast, by Route of Administration
9.20. North America Drug and Gene Delivery System Market Attractiveness Analysis

Section 10 Europe Drug and Gene Delivery System Market Analysis

…….

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/112017/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Related Articles

Back to top button